BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16205766)

  • 1. To what extent do cancer patients use complementary and alternative medicine?
    Deng G; Cassileth BR
    Nat Clin Pract Oncol; 2005 Oct; 2(10):496-7. PubMed ID: 16205766
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.
    Aydin Avci I; Koç Z; Sağlam Z
    J Clin Nurs; 2012 Mar; 21(5-6):677-88. PubMed ID: 21714820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-application of complementary and alternative medicine by patients with gynecologic cancer.
    Akyuz A; Dede M; Cetinturk A; Yavan T; Yenen MC; Sarici SU; Dilek S
    Gynecol Obstet Invest; 2007; 64(2):75-81. PubMed ID: 17308388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of use of complementary and alternative therapies among patients with cancer.
    Fouladbakhsh JM; Stommel M; Given BA; Given CW
    Oncol Nurs Forum; 2005 Nov; 32(6):1115-22. PubMed ID: 16270107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia.
    Oh B; Butow P; Mullan B; Beale P; Pavlakis N; Rosenthal D; Clarke S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):342-9. PubMed ID: 21114784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
    Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
    Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pharmacological interventions used by cancer patients during chemotherapy in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2011 Apr; 15(2):178-84. PubMed ID: 20863758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary-alternative medicine among cancer patients in the western region of Turkey.
    Tarhan O; Alacacioglu A; Somali I; Sipahi H; Zencir M; Oztop I; Dirioz M; Yilmaz U
    J BUON; 2009; 14(2):265-9. PubMed ID: 19650177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change and stability: use of complementary and alternative medicine in Israel: 1993, 2000 and 2007.
    Shmueli A; Igudin I; Shuval J
    Eur J Public Health; 2011 Apr; 21(2):254-9. PubMed ID: 20375024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
    Swarup AB; Barrett W; Jazieh AR
    Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.
    Mao JJ; Farrar JT; Xie SX; Bowman MA; Armstrong K
    Complement Ther Med; 2007 Mar; 15(1):21-9. PubMed ID: 17352968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of decision-making processes for conventional and complementary medicine in cancer patients.
    Carmady B; Smith CA; Colagiuri B
    Complement Ther Clin Pract; 2013 Feb; 19(1):32-5. PubMed ID: 23337562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-West medicine.
    Hui KK; Hui EK; Johnston MF
    Integr Cancer Ther; 2006 Mar; 5(1):56-62. PubMed ID: 16484714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicines (including traditional Maori treatments) used by presenters to an emergency department in New Zealand: a survey of prevalence and toxicity.
    Nicholson T
    N Z Med J; 2006 May; 119(1233):U1954. PubMed ID: 16680171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.